This review examines the use of combinations of oral antiplatelet agents with oral anticoagulant agents for long-term secondary prevention in patients with cardiovascular diseases such as myocardial infarction (MI), mechanical valve replacement, coronary artery stent implantation, and chronic atrial fibrillation (AF).
|Original language||English (US)|
|Journal||P and T|
|State||Published - Jan 1 2001|
All Science Journal Classification (ASJC) codes
- Pharmacology (medical)